{
  "id": "CD015219.PUB2",
  "draft": "Is favipiravir (an antiviral drug) effective for treating COVID-19?\n\nKey Messages\n- We are unsure if favipiravir works for COVID-19 because the evidence is not strong enough, and it may cause more unwanted or harmful effects (side effects).\n- Researchers studied favipiravir in several randomized controlled trials to see how well it works for people with COVID-19. They found that favipiravir may not make a difference in whether people need to go to the hospital, need oxygen therapy, or recover from COVID-19.\n- We need more research to understand the benefits and harms of using favipiravir to treat COVID-19 and to get high-quality evidence to inform decisions.\n\nWhat is COVID-19 and why is it a problem?\nCOVID-19 is an illness caused by a virus called SARS-CoV-2 (a type of coronavirus). It has been challenging healthcare systems and societies worldwide since its outbreak. COVID-19 can lead to severe respiratory problems, and its impact has been felt globally. Common treatments for COVID-19 include supportive care, such as rest, hydration, and oxygen therapy, as well as experimental antiviral treatments.\n\nWhat is favipiravir and how is it used in treating COVID-19?\nFavipiravir is an antiviral drug that has been suggested as a potential treatment for COVID-19. Researchers studied it in several randomized controlled trials to see how well it works for people with COVID-19. People usually take a high dose on the first day, followed by a lower dose for several days. However, it is still unclear if favipiravir is a useful treatment for COVID-19.\n\nWhat did the review authors want to find out?\nWe wanted to see how well favipiravir worked for people with COVID-19 compared to no treatment, standard care (the usual care given to people with COVID-19), or other antiviral drugs. We wanted to find out if favipiravir, compared to other treatments, could reduce the risk of death, prevent people from needing to go to the hospital, stop the illness from getting worse and requiring a breathing machine (mechanical ventilation), or help people get better faster.\n\nWhat methods did we use?\nWe searched for studies comparing favipiravir to other treatments for COVID-19, summarized their results, and rated our confidence in the evidence.\n\nWhat did we find?\nWe found 25 studies that involved 5750 adults with COVID-19. Most participants were hospitalized with mild to moderate disease and were under 60 years of age. The studies were conducted in several countries. Most studies compared favipiravir to a placebo (a dummy treatment) or the usual care given to people with COVID-19 (known as 'standard of care'). Treatment usually started with a high dose on the first day, followed by lower doses for one to two weeks.\n\nWhat are the main results of favipiravir for COVID-19?\nFavipiravir may make little to no difference in the need for admission to hospital, the progression to oxygen therapy, or the time to clinical improvement for people with COVID-19. However, it may cause more side effects. We are not sure if favipiravir reduces the risk of dying from any cause, needing a breathing machine, or having other serious side effects.\n\nWhat are the limitations of the evidence?\nThe evidence is limited because the studies were very small, and in some studies, people knew which treatment they were getting. This can affect the results. Not all studies reported data on all outcomes of interest.\n\nIs the evidence up to date?\nThe evidence is up to date to July 2023.\n\nFuture research should explore the benefits and harms of using favipiravir to treat COVID-19. We need high-quality evidence to help people make informed decisions.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 614,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 36,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 17.055555555555557,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 20,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 20.0 to <13.0 (median)"
        },
        "active_voice": {
          "value": 65,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 35,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 20,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "nouns": {
          "value": 146,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "flesch_reading_ease": {
          "value": 61.521330980817964,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 8.915412595005431,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 8.315790807093737,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 8.953224755700322,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 13.20658704306913,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 43.43992037640246,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 4.5,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 13.14889156509222,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "dale_chall_readability": {
          "value": 6.323593992037641,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 213,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words": {
          "value": 98,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "long_words": {
          "value": 162,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        }
      },
      "word_count_status": {
        "word_count": 614,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 614 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 8,
        "P50_count": 0,
        "P75_count": 9,
        "P90_count": 1,
        "P10_count": 0,
        "BEYOND_P90_count": 0,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 44.44444444444444,
        "P50_percentage": 0,
        "P75_percentage": 50,
        "P90_percentage": 5.555555555555555,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 0,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 94.44444444444444,
        "overall_assessment": "HIGHLY CONFORMS TO TYPICAL PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This is a strong draft that is clear, accurate, and well-structured. All critical checks for completeness, formatting, and accuracy have passed. However, a few improvements are needed to enhance clarity and style before approval. The main issues are the use of passive voice, a repetitive conclusion, and some slightly vague phrasing.\n\nHere are the top 3 improvements needed:\n\n1. **Use Active Voice Consistently:** The summary contains several instances of passive voice, which can make the text less direct. The style guide recommends using active voice.\n    - **Problematic sentence:** \"The studies were conducted in several countries.\"\n    - **Why it's a problem:** This phrasing is indirect. It's clearer to state who performed the action.\n    - **Suggested rewrite:** \"Researchers conducted the studies in several countries.\"\n\n2. **Remove Redundant Conclusion:** The final paragraph of the summary repeats the third key message almost word-for-word, which is unnecessary.\n    - **Problematic text:** The final paragraph states, \"Future research should explore the benefits and harms of using favipiravir to treat COVID-19. We need high-quality evidence to help people make informed decisions.\" This is nearly identical to the third key message.\n    - **Why it's a problem:** Repetition can make the summary feel longer than necessary. The key messages at the start are sufficient to convey this point.\n    - **Suggested rewrite:** Remove the final two sentences from the main text. The summary can end effectively with the evidence currency statement.\n\n3. **Clarify Vague Phrasing in Limitations:** In the limitations section, the word \"This\" could refer to one or both of the issues mentioned previously, making it slightly ambiguous.\n    - **Problematic sentence:** \"The evidence is limited because the studies were very small, and in some studies, people knew which treatment they were getting. This can affect the results.\"\n    - **Why it's a problem:** It is not immediately clear if \"This\" refers to the small study size, the lack of blinding, or both.\n    - **Suggested rewrite:** \"These factors can make the results less reliable.\"",
      "pls_evaluation_summary": "The linguistic analysis shows the draft highly conforms to typical PLS patterns, with 94.4% of metrics falling within the best quartile for readability and clarity. The text is well under the word count limit and has excellent readability scores. The single significant deviation is the 'passive_voice' metric, which is in the P90 range (20 instances). This statistical finding supports the editorial recommendation to convert passive constructions to active voice to improve directness and align with style guidelines."
    }
  ]
}